Related Experiment Video

Updated: Feb 8, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.9K

Cancer mucosa antigens: novel immunotherapeutic targets

Liu Hong1, Daiming Fan

  • 1State Key Laboratory of Cancer Biology & Institute of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shaanxi Province, China.

Expert Opinion on Therapeutic Targets
|May 16, 2008
PubMed
Abstract

Insights

Cancer mucosa antigens (CMAs) show promise as specific targets for cancer immunotherapy, addressing challenges in current treatments. Further research is needed to optimize their use in clinical trials for improved cancer treatment outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • Cancer immunotherapy faces challenges due to a lack of specific targets and weak immune responses.
  • Cancer mucosa antigens (CMAs) are emerging as promising targets for developing effective cancer immunotherapies.

Purpose of the Study:

  • To review the current research landscape of cancer mucosa antigens (CMAs).
  • To discuss the potential of CMAs in augmenting anti-cancer immune responses.
  • To explore future directions in identifying CMAs and their therapeutic applications.

Main Methods:

  • Literature review of studies investigating CMAs in cancer immunotherapy.
  • Analysis of evidence demonstrating the use of CMAs to enhance anti-cancer immunity.
  • Exploration of future research avenues for CMA identification and application.

Main Results:

  • Evidence suggests CMAs can be effectively used to boost immune responses against cancer.
  • Progress has been made in utilizing CMAs for therapeutic purposes.
  • CMAs represent a novel class of targets with significant potential in cancer treatment.

Conclusions:

  • Cancer mucosa antigens (CMAs) are viable novel targets for immunotherapy.
  • Additional research is crucial to enhance the success rates of cancer immunotherapy in clinical settings.

More Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.9K
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

15.3K

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
3.3K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.6K
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
2.4K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.6K